Mint Explainer | How the NPPA plans to rein in cancer drug prices
India’s NPPA has approved capping trade margins on non-scheduled cancer drugs at 30% of MRP, targeting markups that averaged about 170% and reached 700% in some cases. What it means for patients and how will the cap work?
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)